We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Graham Holdings Company
GHC
$5.02B
| $11.4M | 0.07% |
17,975
-3,293
| -15% | -$1.94M |
|
|
JCP
252
DELISTED
J.C. Penney Company, Inc.
JCP
| $11.4M | 0.07% |
1,352,776
-99,058
| -7% | -$771K |
|
253
Digital Realty Trust
DLR
$71.7B
| $11.4M | 0.07% |
172,371
-25,976
| -13% | -$1.78M |
|
254
Gildan
GIL
$10.6B
| $11.3M | 0.07% |
383,304
+163,786
| +75% | +$4.79M |
|
255
H&R Block
HRB
$5.86B
| $11.3M | 0.07% |
+352,002
| New | +$11.8M |
|
|
AFSI
256
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $11.1M | 0.07% |
391,100
+369,448
| +1,706% | +$9.99M |
|
257
News Corp Class B
NWS
$17.5B
| $11.1M | 0.07% |
698,491
-68,834
| -9% | -$1.08M |
|
|
ELP
258
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $11.1M | 0.07% |
2,640,280
+677,440
| +35% | +$3.1M |
|
259
Avis
CAR
$5.02B
| $11.1M | 0.07% |
187,358
+154,775
| +475% | +$9.44M |
|
260
Bristol-Myers Squibb
BMY
$132B
| $11M | 0.07% |
+170,800
| New | +$10.7M |
|
|
MXIM
261
DELISTED
Maxim Integrated Products
MXIM
| $10.8M | 0.07% |
308,984
-21,194
| -6% | -$724K |
|
|
SVU
262
DELISTED
SUPERVALU Inc.
SVU
| $10.7M | 0.07% |
131,894
+28,403
| +27% | +$2.04M |
|
263
Automatic Data Processing
ADP
$108B
| $10.7M | 0.07% |
+125,366
| New | +$10.8M |
|
|
CBD
264
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $10.4M | 0.06% |
350,320
+313,858
| +861% | +$10.3M |
|
|
OVTI
265
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $10.4M | 0.06% |
394,831
+55,094
| +16% | +$1.48M |
|
|
CBL
266
DELISTED
CBL& Associates Properties, Inc.
CBL
| $10.4M | 0.06% |
525,112
+216,074
| +70% | +$4.35M |
|
|
MRO
267
DELISTED
Marathon Oil Corporation
MRO
| $10.4M | 0.06% |
396,882
+259,632
| +189% | +$7.04M |
|
268
Ambarella
AMBA
$3.81B
| $10.3M | 0.06% |
+136,350
| New | +$8.28M |
|
|
TIME
269
DELISTED
Time Inc.
TIME
| $10.3M | 0.06% |
458,278
+60,799
| +15% | +$1.45M |
|
270
Super Micro Computer
SMCI
$20.1B
| $10.3M | 0.06% |
3,096,330
+160,380
| +5% | +$590K |
|
|
BIG
271
DELISTED
Big Lots, Inc.
BIG
| $10.2M | 0.06% |
212,292
-16,285
| -7% | -$769K |
|
|
CMO
272
DELISTED
Capstead Mortgage Corp.
CMO
| $10.1M | 0.06% |
859,195
-392,987
| -31% | -$4.73M |
|
273
Trane Technologies
TT
$106B
| $10.1M | 0.06% |
148,375
-40,391
| -21% | -$2.67M |
|
274
Wolfspeed
WOLF
$1.71B
| $10.1M | 0.06% |
283,353
+32,778
| +13% | +$1.18M |
|
275
Autodesk
ADSK
$52.6B
| $10M | 0.06% |
+171,320
| New | +$10.1M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.